Evidence map›Paper›PMID 42652926›Full record

ArticleLife (Basel, Switzerland)2026

Lamotrigine-Induced Toxic Epidermal Necrolysis with Multiorgan Failure, Pneumatosis Intestinalis and Chronic Ocular Complications.

Jakub Szrama, Piotr Smuszkiewicz, Amadeusz Woźniak, Ashish Lohani, Krzysztof Zwoliński, Paweł Sobczyński, Nina Łabędź, Aleksandra Dańczak-Pazdrowska, Paweł Pazdrowski, Anna Mikołajczyk-Lorkiewicz and 3 more

Abstract readCase Reports
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jakub SzramaDepartment of Anesthesiology, Intensive Therapy and Pain Management, Poznan University of Medical Sciences, 60-355 Poznan, Poland.ORCID 0000-0002-3647-9119
Piotr SmuszkiewiczDepartment of Anesthesiology, Intensive Therapy and Pain Management, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Amadeusz WoźniakDepartment of Anesthesiology, Intensive Therapy and Pain Management, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Ashish LohaniDepartment of Anesthesiology, Intensive Therapy and Pain Management, Poznan University of Medical Sciences, 60-355 Poznan, Poland.ORCID 0000-0001-8617-2820
Krzysztof ZwolińskiDepartment of Anesthesiology, Intensive Therapy and Pain Management, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Paweł SobczyńskiDepartment of Anesthesiology, Intensive Therapy and Pain Management, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Nina ŁabędźDepartment of Dermatology, Poznan University of Medical Science, 60-355 Poznan, Poland.
Aleksandra Dańczak-PazdrowskaDepartment of Dermatology, Poznan University of Medical Science, 60-355 Poznan, Poland.
Paweł PazdrowskiDepartment of Ophthalmology, Chair of Ophthalmology and Optometry, Poznan University of Medical Sciences, 60-780 Poznan, Poland.ORCID 0009-0007-9288-6257
Anna Mikołajczyk-LorkiewiczDepartment of Ophthalmology, Chair of Ophthalmology and Optometry, Poznan University of Medical Sciences, 60-780 Poznan, Poland.
Joanna WojciechowskaDepartment of Ophthalmology, Chair of Ophthalmology and Optometry, Poznan University of Medical Sciences, 60-780 Poznan, Poland.
Marcin StopaDepartment of Ophthalmology, Chair of Ophthalmology and Optometry, Poznan University of Medical Sciences, 60-780 Poznan, Poland.ORCID 0000-0001-9540-9500
Adriana PolańskaDepartment of Dermatology and Venerology, Poznan University of Medical Sciences, 60-780 Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxic epidermal necrolysis (TEN) is a rare, life-threatening mucocutaneous adverse drug reaction associated with extensive epidermal necrosis and severe systemic complications. We report the case of a 25-year-old woman who developed severe lamotrigine-induced TEN four weeks after treatment initiation. The disease rapidly progressed to involve approximately 60% of the body surface area, requiring intensive care unit admission, mechanical ventilation, and multidisciplinary management. Treatment included high-dose intravenous methylprednisolone, intravenous immunoglobulins, etanercept, plasmapheresis, and comprehensive supportive care. During hospitalization, the patient developed gastrointestinal complications manifested by pneumatosis intestinalis and portal venous gas, raising suspicion of bowel ischemia and prompting exploratory laparotomy. Following treatment, gradual clinical improvement and complete resolution of the cutaneous lesions were achieved. However, persistent ocular sequelae developed, including meibomian gland dysfunction, punctate epithelial erosions, conjunctival scarring, trichiasis, tear film instability, and early corneal neovascularization, requiring long-term ophthalmological follow-up. To provide clinical context, a narrative review of the literature on the diagnosis, multidisciplinary management, gastrointestinal manifestations, ocular complications, and systemic treatment of TEN was performed. A comprehensive literature search was conducted to identify relevant articles focusing on the intensive care management and specific organ-related manifestations of Toxic Epidermal Necrolysis (TEN). The gathered literature was narratively synthesized to present a cohesive update on current clinical practices and management controversies. This case highlights the potentially devastating multiorgan course of TEN and emphasizes the importance of early recognition, specialized intensive care, and long-term multidisciplinary follow-up.

Indexed as

chronic ocular complicationsintensive therapylamotriginemultiorgan failurepneumatosis intestinalisportal venous gastoxic epidermal necrolysis

Identifiers

PMID42652926
PMCPMC13514332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.